Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Commentary and Review
  • Published:

HIV viral load markers in clinical practice

Nature Medicine volume 2, pages 625–629 (1996)Cite this article

Plasma HIV RNA determinations are an important prognostic marker of disease progression and, when used appropriately, provide a valuable tool for the management of individual patients. But what constitutes appropriate use?

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Wei, X. et al. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373, 117 (1995).

    Article  CAS  PubMed  Google Scholar 

  2. Ho, D.D. et al. Rapid turnover of plasma virions and CD4+ lymphocytes in HIV-1 infection. Nature 373, 123–126 (1995).

    Article  CAS  PubMed  Google Scholar 

  3. Perelson, A.S., Neumann, A.U., Markowitz, M., Leonard, J.M. & Ho, D.D. HIV-1 dynamics in vivo: Virion clearnace rate, infected cell life-span, and viral generation time. Science 271, 1582–1586 (1996).

    Article  CAS  PubMed  Google Scholar 

  4. Ho, D.D., Moudgil, T. & Alam, M. Qunatitation of human immunodeficiency virus type 1 in the blood of infected persons. N. Engl. J. Med. 321, 1621–1625 (1989).

    Article  CAS  PubMed  Google Scholar 

  5. Coombs, R.W. et al. Plasma viremia in human immunodeficiency virus infection. N. Engl. J. Med. 321, 1626–1631 (1989).

    Article  CAS  PubMed  Google Scholar 

  6. Piatak, M., Jr et al. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 259, 1749–1754 (1993).

    Article  CAS  PubMed  Google Scholar 

  7. Pachl, C. et al. Rapid and precise quantification of HIV-1 RNA in plasma using a branched DNA signal amplification assay. J. Acquir. Immune Defic. Syndr. Hum. Retrovir. 8, 446–454 (1995).

    Article  CAS  Google Scholar 

  8. Mulder, J. et al. Rapid and simple PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma: Application to acute retroviral infection. J. Clin. Microbiol. 32, 292–300 (1994).

    CAS  PubMed  PubMed Central  Google Scholar 

  9. Kievits, T. et al. NASBA isothermal enzymatic in vitro nucleic acid amplification optimized for the diagnosis of HIV-1 infection. J. Virol. Methods 35, 273–286 (1991).

    Article  CAS  PubMed  Google Scholar 

  10. Cao, Y. et al. Clinical evaluation of branched DNA signal amplification for quantifying HIV type 1 in human plasma. AIDS Res. Hum. Retrovir. 11, 353–361 (1995).

    Article  CAS  PubMed  Google Scholar 

  11. Lin, H.J. et al. Multicenter evaluation of quantification methods for plasma human immunodeficiency virus type 1 RNA. J. Infect. Dis. 170, 553–562 (1994).

    Article  CAS  PubMed  Google Scholar 

  12. Brambilla, D. et al. Variation in estimates of HIV-1 plasma RNA concentration among laboratories and assay kits. 3rd Conference on Retroviruses and Opportunistic Infections, Jan. 28–Feb. 1, 1996, 155, abst. 550 (Washington, DC).

    Google Scholar 

  13. Holodniy, M., Mole, L., Winters, M. & Merigan, T.C. Diurnal and short-term stability of HIV virus load as measured by gene amplification. J. Acquir. Immune Defic. Syndr. 7, 363–368 (1994).

    CAS  PubMed  Google Scholar 

  14. Clark, S.J. et al. High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection. N. Engl. J. Med. 324, 954 (1991).

    Article  CAS  PubMed  Google Scholar 

  15. Holodniy, M. et al. Detection and quantification of human immunodeficiency virus RNA in patient serum by use of the polymerase chain reaction. J. Infect. Dis. 163, 862–866 (1991).

    Article  CAS  PubMed  Google Scholar 

  16. Stein, D.S., Korvick, J.A. & Vermund, S.H. CD4+ lymphocyte cell enumeration for prediction of clinical course of human immunodeficiency virus disease: a review. J. Infect. Dis. 165, 352–363 (1992).

    Article  CAS  PubMed  Google Scholar 

  17. Raboud, R.M. et al. Quantification of the variation due to laboratory and physiologic sources in CD4 lymphocyte counts of clinically stable HIV-infected individuals. J. Acquir. Immune Defic. Syndr. Hum. Retrovir. 10 (suppl. 2), S67–S73 (1995).

    Google Scholar 

  18. Hoover, D.R. et al. Effect of CD4+ cell count measurement variability on staging HIV-1 infection. J. AIDS 5, 794–802 (1992).

    CAS  Google Scholar 

  19. O'Brien, W.A. et al. Changes in plasma HIV-1 RNA and CD4+ Lymphocyte counts and the risk of progression to AIDS. N. Engl. J. Med. 334, 425–431 (1996).

    Article  Google Scholar 

  20. Coombs, R.W. et al. Association of plasma human immunodeficiency virus type-1 RNA level with risk of clinical progression in patients with advanced infection. J. Infect. Dis. (in the press).

  21. Welles, S.L. et al. Prognostic value of plasma HIV-1 RNA levels in patients with advanced HIV-1 disease and with little or no zidovudine therapy. J. Infect. Dis. (in the press).

  22. Mellors, J.W. et al. Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann. Intern. Med. 122, 573–579 (1995).

    Article  CAS  PubMed  Google Scholar 

  23. Mellors, J.W. et al. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science (in the press).

  24. Kappes, J.C. et al. Assessment of antiretroviral therapy by plasma viral load testing: standard and ICD HIV-1 p24 antigen and viral RNA j(QC-PCR) assays compared. J. Acquir. Immune Defic. Syndr. Hum. Retrovir. 10, 139–149 (1995).

    Article  CAS  Google Scholar 

  25. Hammer, S.M., Katzenstein, D.A., Hughes, M.D., Hirsch, M.S., Merigan, T.C. Virologic markers and outcome in ACTG 175. 3rd Conference on Retroviruses and Opportunistic Infections, Jan. 28–Feb. 1, 1996, 175, abst. S24 (Washington, DC).

    Google Scholar 

  26. Eron, J. et al. Treatment with lamivudine, zidovudine, or both in HIV-positive patients with 200 to 500 CD4 cells per cubic millimeter. N. Engl. J. Med. 333, 1662–1669 (1995).

    Article  CAS  PubMed  Google Scholar 

  27. Danner, S.A. et al. A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, an inhibitor of HIV-1 protease. N. Engl. J. Med. 333, 1528–1533 (1995).

    Article  CAS  PubMed  Google Scholar 

  28. Markowitz, M. et al. A preliminary study of ritonavir, an inhibitor of HIV-1 protease, to treat HIV-1 infection. N. Engl. J. Med. 333, 1534–1539 (1995).

    Article  CAS  PubMed  Google Scholar 

  29. Heath-Chiozzi, M. et al. Anti-HIV activity and lymphocyte surrogate marker response dynamics to ritonavir therapy in advanced HIV immunodeficiency. 3rd Conference on Retroviruses and Opportunistic Infections, Jan. 28–Feb. 1, 1996, 162, abst. LB6b (Washington, DC).

    Google Scholar 

  30. Havlir, D., McLaughlin, M.M. & Richman, D.D. A pilot study to evaluate the development of resistance to nevirapine in asymptomatic human asymptomatic human immunodeficiency virus-infected patients with CD4+ cell counts of >500/mm3: AIDS Clinical Trials Group Protocol 208. J. Infect. Dis. 172, 1379–1383 (1995).

    Article  CAS  PubMed  Google Scholar 

  31. Holodniy, M. et al. Determination of human immunodeficiency virus RNA in plasma and cellular viral DNA genotypic zidovudine resistance and viral load during zidovudine-didanosine combination therapy. J. Virol. 69, 3510–3516 (1995).

    CAS  PubMed  PubMed Central  Google Scholar 

  32. Staprans, S.I. et al. Activation of virus replication after vaccination of HIV-1 infected individuals. J. Exp. Med. 182, 1727–1737 (1995).

    Article  CAS  PubMed  Google Scholar 

  33. O'Brien, W.A. et al. Human immunodeficiency virus-type 1 replication can be increased in peripheral blood of seropositive patients after influenza vaccination. Blood 86, 1082–1089 (1995).

    CAS  PubMed  Google Scholar 

Download references

Author information

Author notes

  1. M.S. Saag: University of Alabama at Birmingham, 908 20th Street South Birmingham, Alabama 35294-2050, USA

Authors and Affiliations

  1. University of Alabama at Birmingham,

    M.S. Saag & G.M. Shaw

  2. Stanford University and the Palo Alto Veterans Affairs Health Care System,

    M. Holodniy

  3. University of Colorado Health Sciences Center,

    D.R. Kuritzkes

  4. University of California Los Angeles School of Medicine and West Los Angeles Veterans Affairs Medical Center,

    W.A. O'Brien

  5. University of Washington,

    R. Coombs

  6. University of California San Francisco School of Medicine,

    M.E. Poscher & P.A. Volberding

  7. International AIDS Society, USA

    D.M. Jacobsen

  8. University of California San Diego and San Diego Veterans Affairs Medical Center,

    D.D. Richman

Authors
  1. M.S. Saag
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Holodniy
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. D.R. Kuritzkes
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. W.A. O'Brien
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. R. Coombs
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. M.E. Poscher
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. D.M. Jacobsen
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. G.M. Shaw
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. D.D. Richman
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. P.A. Volberding
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Saag, M., Holodniy, M., Kuritzkes, D. et al. HIV viral load markers in clinical practice. Nat Med 2, 625–629 (1996). https://doi.org/10.1038/nm0696-625

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm0696-625

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing